PROCEPT BioRobotics: Vanguard reports 4.96% stake
PROCEPT BioRobotics Corp (PRCT) is the issuer whose common stock is covered by Vanguard Capital Management’s amended ownership report.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp (PRCT) is the issuer whose common stock is covered by Vanguard Capital Management’s amended ownership report. Vanguard Capital Management reported beneficial ownership of 2,845,781 shares, or 4.96% of the class. It reported sole voting power over 433,130 shares and sole dispositive power over 2,845,781 shares, with zero shared voting or dispositive power. The reported securities include holdings attributed to Vanguard Capital Management LLC and named affiliates or business divisions, including Vanguard funds and client accounts over which those entities exercise voting and/or dispositive power.
Key Figures
Key Terms
beneficially owned regulatory
Sole Voting Power regulatory
Sole Dispositive Power regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.